Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BIOA
LYEL
Add up to 3 more stocks
BIOA
BioAge Labs Inc.
-2.91%
$6.17-0.19Delayed quote: Oct 6, 2026, 12:50 PM EDT
Market Cap
$232.49M
52W Range
$5.04 - $25.96
LYEL
Lyell Immunopharma, Inc.
-0.50%
$9.03-0.04Delayed quote: Oct 6, 2026, 12:50 PM EDT
Market Cap
$221.15M
52W Range
$8.66 - $45.00
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.62 | 0.95 |
| P/S Ratio | 22.45 | 8190.81 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 99.4% | -31952.8% |
| Operating Margin | -1026.3% | -566038.9% |
| Net Margin | -912.3% | -920285.2% |
| ROE | -25.2% | -106.3% |
| ROA | -23.8% | -79.9% |
| ROIC | -28.1% | -70.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 17.19 | 5.36 |
| Quick Ratio | 17.19 | 5.36 |
| Debt/Equity | 0.01 | 0.16 |
| Interest Coverage | -133.11 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.